Detalles de la búsqueda
1.
Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors.
BMC Cancer;
23(1): 547, 2023 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37322411
2.
Overall survival of patients with hepatocellular carcinoma treated with sintilimab and disease outcome after treatment discontinuation.
BMC Cancer;
23(1): 1017, 2023 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37867191
3.
A stable and reliable animal model for hepatocellular carcinoma with portal vein tumor thrombus.
Hepatobiliary Pancreat Dis Int;
21(1): 90-93, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33810986
4.
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial.
Nat Med;
30(3): 708-715, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38242982
5.
Preoperative and Prognostic Prediction of Microvascular Invasion in Hepatocellular Carcinoma: A Review Based on Artificial Intelligence.
Technol Cancer Res Treat;
22: 15330338231212726, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37933176
6.
Network pharmacology-based analysis of Resinacein S against non-alcoholic fatty liver disease by modulating lipid metabolism.
Front Nutr;
10: 1076569, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36866057
7.
A reasonable identification of the early recurrence time based on microvascular invasion for hepatocellular carcinoma after R0 resection: A multicenter retrospective study.
Cancer Med;
12(9): 10294-10302, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36880150
8.
Efficacy and safety of TACE combined with lenvatinib and PD-1 inhibitors for unresectable recurrent HCC: A multicenter, retrospective study.
Cancer Med;
12(10): 11513-11524, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36999793
9.
Laparoscopic and open liver resection for hepatocellular carcinoma with type 2 diabetes mellitus: multicenter propensity score-matched study.
Hepatol Int;
17(5): 1251-1264, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37060489
10.
Efficacy and safety of a triple combination of atezolizumab, bevacizumab plus GEMOX for advanced biliary tract cancer: a multicenter, single-arm, retrospective study.
Therap Adv Gastroenterol;
16: 17562848231160630, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37007215
11.
Intensity-modulated radiotherapy combined with systemic atezolizumab and bevacizumab in treatment of hepatocellular carcinoma with extrahepatic portal vein tumor thrombus: A preliminary multicenter single-arm prospective study.
Front Immunol;
14: 1107542, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36875125
12.
Perioperative and long-term survival outcomes of laparoscopic versus laparotomic hepatectomy for BCLC stages 0-A hepatocellular carcinoma patients associated with or without microvascular invasion: a multicenter, propensity score matching analysis.
Hepatol Int;
16(4): 892-905, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35704267
13.
Prognostic Comparison Between Liver Resection and Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Patients With Bile Duct Tumor Thrombus: A Propensity-Score Matching Analysis.
Front Oncol;
12: 835559, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35372001
14.
Impact of type 2 diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after laparoscopic liver resection: A multicenter retrospective study.
Front Oncol;
12: 979434, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36591472
15.
Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with portal vein tumor thrombus in the real world.
Front Oncol;
12: 954203, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36505818
16.
Efficacy and Safety of Transarterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma Associated with Bile Duct Tumor Thrombus: A Real-World Retrospective Cohort Study.
Cancer Manag Res;
13: 3551-3560, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33953609
17.
Hepatocellular Carcinoma with Portal Vein Tumor Thrombus versus Hepatocellular Carcinoma with Biliary Tumor Thrombus: Better or Worse Prognoses? [Letter].
Cancer Manag Res;
13: 987-988, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33568944
Resultados
1 -
17
de 17
1
Próxima >
>>